Novel Drug Delivery Systems for Chinese Medicines

This book describes the essential and cutting-edge concepts based on the frontier of pharmaceutical research in TCM, underlying scientific principles, and current advancements of drug delivery systems for Chinese medicines, including sustained-release drug delivery systems, trans-nasal drug delivery systems, dermal and transdermal drug delivery systems, etc. Novel carriers and emerging technologies (such as 3D printing) are also covered. The book provides readers with an overall picture of drug delivery systems for Chinese medicines and also yields benefits for the pharmaceutical industry with regard to TCM-based drug development.

This book describes the essential and cutting-edge concepts based on the frontier of pharmaceutical research in TCM, underlying scientific principles, and current advancements of drug delivery systems for Chinese medicines, including sustained-release drug delivery systems, trans-nasal drug delivery systems, dermal and transdermal drug delivery systems, etc. Novel carriers and emerging technologies (such as 3D printing) are also covered. The book provides readers with an overall picture of drug delivery systems for Chinese medicines and also yields benefits for the pharmaceutical industry with regard to TCM-based drug development.

Dr. Nianping Feng is a Chair Professor and the Director of the Department of Pharmaceutical Sciences at Shanghai University of Traditional Chinese Medicine, Shanghai, China. He received his Ph. D. degree from China Pharmaceutical University in June 1997 and took up a lectureship at the same university prior to joining the Shanghai University of Traditional Chinese Medicine in Oct. 1998. Dr. Feng worked as a senior research scientist at Purdue University from Sept. 2012 to Sept. 2013. His research interests include novel drug delivery systems, pharmaceutical nanotechnologies and TCM-base new drug development. Dr. Feng has co-authored more than 200 research papers, reviews, and patents.

Dr. Zhijun Yang is a Professor at the School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. He graduated from Shenyang College of Pharmacy, received his Ph.D. from Chiba University. He was an AP, a lecturer in China Pharmaceutical University, a researcher in Gifu Pharmaceutical University and TaiYo Pharmaceutical Industry Ltd., a postdoctoral at the University of British Columbia, a scientist in Northern Lipid Inc. Canada. Dr. Yang attained remarkable results both in publications and pharmaceutical products. Currently, Dr. Yang is focusing on the frontest line of the formulation by combining the theories of TCM and DDS.